CST castile resources ltd

rising revenue and wide moats , page-4

  1. 2,039 Posts.
    lightbulb Created with Sketch. 147
    Gotch, you are right about the number of shares on issue - it is about 97m. Your estimate of profit margin at 30%, I suspect, could be on the low side. Costs appear to have plateaued around the $4m per quarter level, and analysis of recent quarterly figures suggests margins may be 60%+ for revenue in excess of that (cost) level. When revenue is in the $100m zone, such figures will be lost in the blur.

    That means that we can project pre-tax earnings of $80m+ when revenues reach the $160m which looks likely in three years time. That yields after-tax earnings of around $56m, or about 58c per share. Picking an appropriate PER is still a guessing game, but most successful, rapidly-growing biotechs seem to be able to justify a PER of at least 25, some much higher. What do you think is reasonable?

    Cheers, Prime
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
5.5¢
Change
0.000(0.00%)
Mkt cap ! $16.81M
Open High Low Value Volume
5.6¢ 5.6¢ 5.5¢ $29.87K 533.6K

Buyers (Bids)

No. Vol. Price($)
2 147620 5.5¢
 

Sellers (Offers)

Price($) Vol. No.
5.6¢ 64317 1
View Market Depth
Last trade - 12.36pm 25/07/2025 (20 minute delay) ?
CST (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.